151 related articles for article (PubMed ID: 36515779)
1. Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists.
Skalafouris C; Blanc AL; Grosgurin O; Marti C; Samer C; Lovis C; Bonnabry P; Guignard B
Int J Clin Pharm; 2023 Apr; 45(2):406-413. PubMed ID: 36515779
[TBL] [Abstract][Full Text] [Related]
2. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.
Zaal RJ; Jansen MM; Duisenberg-van Essenberg M; Tijssen CC; Roukema JA; van den Bemt PM
Int J Clin Pharm; 2013 Oct; 35(5):753-62. PubMed ID: 23715760
[TBL] [Abstract][Full Text] [Related]
3. Drug-related problems identified during medication review before and after the introduction of a clinical decision support system.
Verdoorn S; Kwint HF; Hoogland P; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2018 Apr; 43(2):224-231. PubMed ID: 28971492
[TBL] [Abstract][Full Text] [Related]
4. Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug events.
Skalafouris C; Reny JL; Stirnemann J; Grosgurin O; Eggimann F; Grauser D; Teixeira D; Jermini M; Bruggmann C; Bonnabry P; Guignard B
BMC Med Inform Decis Mak; 2022 May; 22(1):146. PubMed ID: 35642053
[TBL] [Abstract][Full Text] [Related]
5. Potential drug related problems detected by electronic expert support system in patients with multi-dose drug dispensing.
Tora H; Bo H; Bodil L; Göran P; Birgit E
Int J Clin Pharm; 2014 Oct; 36(5):943-52. PubMed ID: 24974220
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a hybrid decision support system using machine learning with artificial intelligence to safely rule out prescriptions from medication review in daily practice.
Levivien C; Cavagna P; Grah A; Buronfosse A; Courseau R; Bézie Y; Corny J
Int J Clin Pharm; 2022 Apr; 44(2):459-465. PubMed ID: 34978662
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
Desmaele S; De Wulf I; Dupont AG; Steurbaut S
Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
[TBL] [Abstract][Full Text] [Related]
8. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients.
O'Sullivan D; O'Mahony D; O'Connor MN; Gallagher P; Cullinan S; O'Sullivan R; Gallagher J; Eustace J; Byrne S
Drugs Aging; 2014 Jun; 31(6):471-81. PubMed ID: 24797285
[TBL] [Abstract][Full Text] [Related]
9. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
10. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
11. A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands.
Rommers MK; Teepe-Twiss IM; Guchelaar HJ
Drug Saf; 2011 Mar; 34(3):233-42. PubMed ID: 21332247
[TBL] [Abstract][Full Text] [Related]
12. The clinical pharmacist's role in enhancing the relevance of a clinical decision support system.
Cuvelier E; Robert L; Musy E; Rousselière C; Marcilly R; Gautier S; Odou P; Beuscart JB; Décaudin B
Int J Med Inform; 2021 Nov; 155():104568. PubMed ID: 34537687
[TBL] [Abstract][Full Text] [Related]
13. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables.
Wuyts J; Maesschalck J; De Wulf I; Lelubre M; Foubert K; De Vriese C; Boussery K; Goderis G; De Lepeleire J; Foulon V
Res Social Adm Pharm; 2020 Aug; 16(8):1100-1110. PubMed ID: 31759887
[TBL] [Abstract][Full Text] [Related]
14. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.
Covert KL; Mardis CR; Fleming JN; Pilch NA; Meadows HB; Mardis BA; Mohan P; Posadas-Salas M; Srinivas T; Taber DJ
Pharmacotherapy; 2017 Feb; 37(2):159-169. PubMed ID: 27997676
[TBL] [Abstract][Full Text] [Related]
15. Reducing Inappropriate Drug Use in Older Patients by Use of Clinical Decision Support in Community Pharmacy: A Mixed-Methods Evaluation.
Mulder-Wildemors LGM; Heringa M; Floor-Schreudering A; Jansen PAF; Bouvy ML
Drugs Aging; 2020 Feb; 37(2):115-123. PubMed ID: 31782128
[TBL] [Abstract][Full Text] [Related]
16. In-hospital medication reviews reduce unidentified drug-related problems.
Bondesson A; Eriksson T; Kragh A; Holmdahl L; Midlöv P; Höglund P
Eur J Clin Pharmacol; 2013 Mar; 69(3):647-55. PubMed ID: 22955893
[TBL] [Abstract][Full Text] [Related]
17. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
Krähenbühl JM; Kremer B; Guignard B; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
[TBL] [Abstract][Full Text] [Related]
18. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
[TBL] [Abstract][Full Text] [Related]
19. Electronic screening of medical records to detect inpatients at risk of drug-related problems.
Roten I; Marty S; Beney J
Pharm World Sci; 2010 Feb; 32(1):103-7. PubMed ID: 20012362
[TBL] [Abstract][Full Text] [Related]
20. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.
Abunahlah N; Elawaisi A; Velibeyoglu FM; Sancar M
Int J Clin Pharm; 2018 Apr; 40(2):360-367. PubMed ID: 29380236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
